Register for a Clinical Trial
Protocol | GSK 201159 |
Title | A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Effect of 12 weeks of Once-Daily Dosing of the Oral Motilin Receptor Agonist Camicinal, on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects with Gastroparesis |
Phase | II |
Area | Stomach |
Indication | Diabetic Gastropoparesis |
Treatment | Camicinal vs placebo |
Requirement |